Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Emergent Travel Health Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 action is being handled by 1 distinct examiner, JADHAO, SAMADHAN JAISING, who is also the busiest examiner for the portfolio with 1 pending matter. The concentration of the portfolio is further evidenced by its presence in only 1 distinct art unit.
For a practitioner, this highly centralized prosecution profile means that the entire pending strategy rests on a 1 to 1 interaction. Success or failure in this technology area depends on the specific preferences and history of JADHAO, SAMADHAN JAISING. There is no diversification across different art units to mitigate examiner specific risks. The singular focus within 1 art unit suggests a very specific technological niche. Practitioners should prepare for a deep dive into the specific precedents favored by this 1 examiner to ensure the pending action moves toward allowance. This concentrated approach requires a strategy that is highly responsive to the specific feedback provided in the 1 pending action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JADHAO, SAMADHAN JAISING | 1 | 46.9% | +46.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17771782 | CHIKUNGUNYA VIRUS-LIKE PARTICLE VACCINE AND METHODS OF USING THE SAME | JADHAO, SAMADHAN JAISING | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17771782 | CHIKUNGUNYA VIRUS-LIKE PARTICLE VACCINE AND METHODS OF USING THE SAME | JADHAO, SAMADHAN JAISING | 1671 | §103 | Non-Final OA | — | Pending | Apr 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial